Pharmaceutical tablet
Latest Pfizer Inc. Patents:
- Recombinant ROBO2 proteins, compositions, methods and uses thereof
- GLP-1 Receptor Agonists and Uses Thereof
- Benzimidazole Derivatives and Their Use As Inhibitors of ITK For The Treatment of Skin Disease
- Modulators of STING (stimulator of interferon genes)
- Heteroaromatic compounds and their use as dopamine D1 ligands
Description
FIG. 1 is a front elevational view of a pharmaceutical tablet of my new design;
FIG. 2 is a top plan view thereof;
FIG. 3 is a bottom plan view thereof;
FIG. 4 is a side elevation view thereof; and
FIG. 5 is a back elevation view of the pharmaceutical tablet shown in FIGS. 1-4.
Referenced Cited
U.S. Patent Documents
D144978 | June 1946 | Owen |
D190729 | June 1961 | Carter |
D229175 | November 1973 | Libertone et al. |
Patent History
Patent number: D263172
Type: Grant
Filed: Sep 18, 1979
Date of Patent: Feb 23, 1982
Assignee: Pfizer Inc. (New York, NY)
Inventor: Kenneth J. Payne (Greenwich, CT)
Primary Examiner: Veronica O'Keefe
Law Firm: Connolly and Hutz
Application Number: 6/76,589
Type: Grant
Filed: Sep 18, 1979
Date of Patent: Feb 23, 1982
Assignee: Pfizer Inc. (New York, NY)
Inventor: Kenneth J. Payne (Greenwich, CT)
Primary Examiner: Veronica O'Keefe
Law Firm: Connolly and Hutz
Application Number: 6/76,589
Classifications
Current U.S. Class:
D28/2;
D28/1;
D 1/12;
Individual Panel Mount Type (13) (D18/29);
424/14;
424/15
International Classification: D2801;
International Classification: D2801;